OMI vs. PDCO, GLPG, DNA, RNA, AMRX, RXST, NAMS, RCKT, EVO, and GPCR
Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), Galapagos (GLPG), Ginkgo Bioworks (DNA), Avidity Biosciences (RNA), Amneal Pharmaceuticals (AMRX), RxSight (RXST), NewAmsterdam Pharma (NAMS), Rocket Pharmaceuticals (RCKT), Evotec (EVO), and Structure Therapeutics (GPCR). These companies are all part of the "medical" sector.
Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.
In the previous week, Owens & Minor had 24 more articles in the media than Patterson Companies. MarketBeat recorded 33 mentions for Owens & Minor and 9 mentions for Patterson Companies. Patterson Companies' average media sentiment score of 0.33 beat Owens & Minor's score of 0.29 indicating that Owens & Minor is being referred to more favorably in the news media.
Patterson Companies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.
Patterson Companies currently has a consensus target price of $32.56, suggesting a potential upside of 26.38%. Owens & Minor has a consensus target price of $23.29, suggesting a potential upside of 21.22%. Given Owens & Minor's stronger consensus rating and higher possible upside, analysts plainly believe Patterson Companies is more favorable than Owens & Minor.
Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.41% of users gave Patterson Companies an outperform vote while only 48.63% of users gave Owens & Minor an outperform vote.
Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.
Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.37%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.
85.4% of Patterson Companies shares are held by institutional investors. Comparatively, 98.0% of Owens & Minor shares are held by institutional investors. 1.5% of Patterson Companies shares are held by company insiders. Comparatively, 2.6% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Patterson Companies beats Owens & Minor on 13 of the 18 factors compared between the two stocks.
Get Owens & Minor News Delivered to You Automatically
Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Owens & Minor Competitors List
Related Companies and Tools
